股本结构
单位：万股
| 公告日期 | 2025-07-03 | 2025-07-03 | 2025-05-15 | 2025-04-30 | 2025-05-15 | 2025-02-28 |
|---|---|---|---|---|---|---|
| 证券总股本 | 1219.86 | 1219.73 | 1218.91 | 1218.24 | 1207.12 | 1205.90 |
| 普通股本 | 1219.86 | 1219.73 | 1218.91 | 1218.24 | 1207.12 | 1205.90 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 2.64 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-06-17 | 2025-06-04 | 2025-05-12 | 2025-04-25 | 2025-03-31 | 2025-02-24 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-07-03 | 1219.86 | 未披露 | 定期报告 | 2025-06-17 |
| 2025-07-03 | 1219.73 | 未披露 | 定期报告 | 2025-06-04 |
| 2025-05-15 | 1218.91 | 未披露 | 定期报告 | 2025-05-12 |
| 2025-04-30 | 1218.24 | 未披露 | 定期报告 | 2025-04-25 |
| 2025-05-15 | 1207.12 | 2.64 |
更多>>
From December 31, 2024 to March 31, 2025
Issuance of common stock upon vesting of restricted stock
|
2025-03-31 |
| 2025-02-28 | 1205.90 | 未披露 | 定期报告 | 2025-02-24 |
| 2025-02-28 | 1218.24 | 2.64 |
更多>>
From December 31, 2023 to December 31, 2024
Fractional shares retired as a result of reverse split
|
2024-12-31 |
| 2024-11-14 | 1205.45 | 2.64 | 定期报告 | 2024-09-30 |
| 2024-08-08 | 1205.45 | 未披露 | 定期报告 | 2024-08-05 |
| 2024-07-08 | 1209.95 | 未披露 |
更多>>
1-for-10 reverse stock split of its outstanding shares of common stock
|
2024-07-10 |
| 2024-07-08 | 9899.95 | 未披露 | 定期报告 | 2024-07-08 |
| 2024-03-22 | 9895.01 | 2.64 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of common stock upon stock purchase agreement with Gilead at $1.4167 per share for cash, net of issuance costs of $136
Issuance of common stock upon exercise of stock options
Conversion of Series A-1 convertible preferred stock to common stock
Issuance of common stock upon public offering at $1.31 per share for cash, net of issuance costs of $2,207
Conversion of Series A convertible preferred stock to common stock
|
2023-12-31 |
| 2023-12-22 | 9655.06 | 未披露 | 定期报告 | 2023-12-20 |
| 2023-08-10 | 8395.01 | 2.64 |
更多>>
From March 31, 2023 to June 30, 2023
Conversion of Series A convertible preferred stock stock to common stock
Conversion of Series A-1 convertible preferred stock stock to common stock
Issuance of common stock upon public offering at $1.31 per share for cash, net of issuance costs of $2,205
|
2023-06-30 |
| 2023-05-11 | 5472.23 | 1.75 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common stock upon exercise of stock options
|
2023-03-31 |
| 2023-03-15 | 5472.23 | 未披露 | 定期报告 | 2023-03-07 |
| 2023-03-15 | 5471.67 | 1.75 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock upon stock purchase agreement with Gilead at $3.00 per share for cash, no issuance costs
Conversion of Class A common stock to common stock
Issuance of Series A-1 convertible preferred stock upon public offering at $2,000 per share for cash, net of issuance costs of $1,975
Issuance of common stock upon public offering at $2.00 per share for cash, net of issuance costs of $2,713
Issuance of common stock upon exercise of stock options
Vesting of equity grants
|
2022-12-31 |
| 2022-11-14 | 5471.67 | 未披露 | 定期报告 | 2022-11-07 |
| 2022-11-14 | 5613.69 | 1.75 |
更多>>
From June 30, 2022 to September 30, 2022
Conversion of Class A common stock to common stock
Issuance of common stock upon exercise of stock options
|
2022-09-30 |
| 2022-08-11 | 5470.45 | 1.75 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock upon exercise of stock options
|
2022-06-30 |
| 2022-05-16 | 5469.25 | 1.76 | 定期报告 | 2022-04-13 |
| 2022-05-16 | 5469.25 | 1.75 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of Series A-1 convertible preferred stock upon public offering at $2,000 per share for cash, net of issuance costs of $1,975
Issuance of common stock upon public offering at $2.00 per share for cash, net of issuance costs of $2,713
Issuance of common stock upon stock purchase agreement with Gilead at $3.00 per share for cash, no issuance costs
Issuance of common stock upon exercise of stock options
Vesting of equity grants
|
2022-03-31 |
| 2022-03-24 | 5468.84 | 未披露 | 定期报告 | 2022-03-14 |
| 2022-03-03 | 5290.32 | 1.75 |
更多>>
1.Common stock offered by 21,700,000 shares.
2.Series A-1 preferred stock offered by 15,800 shares.
|
2022-03-04 |
| 2022-03-24 | 3120.32 | 0.17 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock upon exercise of stock options
Vesting of restricted stock
Conversion of Series A convertible preferred stock to common stock
|
2021-12-31 |
| 2021-11-10 | 2995.89 | 未披露 | 定期报告 | 2021-11-02 |
| 2021-11-10 | 2990.38 | 0.30 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock upon exercise of stock options
Vesting of restricted stock
|
2021-09-30 |
| 2021-08-12 | 2989.27 | 未披露 | 定期报告 | 2021-08-05 |
| 2021-08-12 | 2987.16 | 0.30 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock upon exercise of stock options
Vesting of restricted stock
|
2021-06-30 |
| 2021-05-12 | 2981.44 | 0.30 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of common stock upon exercise of stock options
Vesting of restricted stock
|
2021-03-31 |
| 2021-03-18 | 2978.93 | 未披露 | 定期报告 | 2021-03-07 |
| 2021-03-18 | 2976.84 | 0.30 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of Series A convertible preferred stock upon public offering at $11,750 per share for cash, net of issuance costs of $2,565
Issuance of common stock upon public offering at $11.75 per share for cash, net of issuance costs of $3,368
Issuance of common stock upon exercise of stock options
Vesting of restricted stock
Vesting of equity grants
|
2020-12-31 |
| 2020-12-11 | 2906.15 | 0.30 |
更多>>
1.Common stock offered by the company 3,400,000 shares.
2.Series A preferred stock offered by the company 2,978 shares.
3.The above discussion is based on 21,841,736 shares of common stock and 3,819,732 shares of Class A common stock outstanding as of September 30, 2020.
|
2020-12-11 |
| 2020-11-12 | 2567.05 | 未披露 | 定期报告 | 2020-11-12 |
| 2020-11-12 | 2566.15 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of common stock upon exercise of stock options
|
2020-09-30 |
| 2020-08-13 | 2565.44 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock upon exercise of stock options
|
2020-06-30 |
| 2020-05-14 | 2564.47 | 未披露 |
更多>>
From December 31, 2019 to March 18, 2020
Issuance of common stock upon exercise of stock options
|
2020-03-18 |
| 2020-03-19 | 2556.61 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Issuance of Series D preferred stock, net of issuance costs of $158
Conversion of Series A, B, C and D preferred stock into common stock upon initial public offering
Issuance of common stock upon initial public offering at $14.00 per share for cash, net of issuance costs of $9,386
Issuance of common stock upon exercise of stock options
|
2019-12-31 |
| 2019-08-12 | 2540.85 | 未披露 |
更多>>
From March 31, 2019 to June 30, 2019
Conversion of Series A, B, C and D preferred stock into common stock upon initial public offering
Issuance of common stock upon initial public offering at $14.00 per share for cash, net of issuance costs of $9,386
|
2019-06-30 |
| 2019-05-20 | 2540.85 | 未披露 | 定期报告 | 2019-05-20 |
| 2019-04-19 | 2158.88 | 未披露 |
更多>>
1.Common stock offered 6,000,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 15,588,756 shares of our common stock outstanding as of February 28, 2019, after giving effect to (i) the automatic conversion of 1,252,440 shares of our preferred stock into an aggregate of 14,582,161 shares of voting common stock upon closing of this offering and (ii) the automatic conversion of 328,071 shares of our preferred stock into 3,819,732 shares of non-voting Class A common stock upon the closing of this offering
3.a 11.643-for-1 split of our common stock effected on April 5, 2019
|
2019-04-18 |
| 2019-05-20 | 100.66 | 166.70 |
更多>>
From December 31, 2018 To March 31, 2019
Issuance of Series D preferred stock, net of issuance costs of $158
|
2019-03-31 |
| 2019-03-22 | 166.70 | 未披露 | 定期报告 | 2019-02-28 |
From December 31, 2024 to March 31, 2025
Issuance of common stock upon vesting of restricted stock
From December 31, 2023 to December 31, 2024
Fractional shares retired as a result of reverse split
1-for-10 reverse stock split of its outstanding shares of common stock
From December 31, 2022 to December 31, 2023
Issuance of common stock upon stock purchase agreement with Gilead at $1.4167 per share for cash, net of issuance costs of $136
Issuance of common stock upon exercise of stock options
Conversion of Series A-1 convertible preferred stock to common stock
Issuance of common stock upon public offering at $1.31 per share for cash, net of issuance costs of $2,207
Conversion of Series A convertible preferred stock to common stock
From March 31, 2023 to June 30, 2023
Conversion of Series A convertible preferred stock stock to common stock
Conversion of Series A-1 convertible preferred stock stock to common stock
Issuance of common stock upon public offering at $1.31 per share for cash, net of issuance costs of $2,205
From December 31, 2022 to March 31, 2023
Issuance of common stock upon exercise of stock options
From December 31, 2021 to December 31, 2022
Issuance of common stock upon stock purchase agreement with Gilead at $3.00 per share for cash, no issuance costs
Conversion of Class A common stock to common stock
Issuance of Series A-1 convertible preferred stock upon public offering at $2,000 per share for cash, net of issuance costs of $1,975
Issuance of common stock upon public offering at $2.00 per share for cash, net of issuance costs of $2,713
Issuance of common stock upon exercise of stock options
Vesting of equity grants
From June 30, 2022 to September 30, 2022
Conversion of Class A common stock to common stock
Issuance of common stock upon exercise of stock options
From March 31, 2022 to June 30, 2022
Issuance of common stock upon exercise of stock options
From December 31, 2021 to March 31, 2022
Issuance of Series A-1 convertible preferred stock upon public offering at $2,000 per share for cash, net of issuance costs of $1,975
Issuance of common stock upon public offering at $2.00 per share for cash, net of issuance costs of $2,713
Issuance of common stock upon stock purchase agreement with Gilead at $3.00 per share for cash, no issuance costs
Issuance of common stock upon exercise of stock options
Vesting of equity grants
1.Common stock offered by 21,700,000 shares.
2.Series A-1 preferred stock offered by 15,800 shares.
From December 31, 2020 to December 31, 2021
Issuance of common stock upon exercise of stock options
Vesting of restricted stock
Conversion of Series A convertible preferred stock to common stock
From June 30, 2021 to September 30, 2021
Issuance of common stock upon exercise of stock options
Vesting of restricted stock
From March 31, 2021 to June 30, 2021
Issuance of common stock upon exercise of stock options
Vesting of restricted stock
From December 31, 2020 to March 31, 2021
Issuance of common stock upon exercise of stock options
Vesting of restricted stock
From December 31, 2019 to December 31, 2020
Issuance of Series A convertible preferred stock upon public offering at $11,750 per share for cash, net of issuance costs of $2,565
Issuance of common stock upon public offering at $11.75 per share for cash, net of issuance costs of $3,368
Issuance of common stock upon exercise of stock options
Vesting of restricted stock
Vesting of equity grants
1.Common stock offered by the company 3,400,000 shares.
2.Series A preferred stock offered by the company 2,978 shares.
3.The above discussion is based on 21,841,736 shares of common stock and 3,819,732 shares of Class A common stock outstanding as of September 30, 2020.
From June 30, 2020 to September 30, 2020
Issuance of common stock upon exercise of stock options
From March 31, 2020 to June 30, 2020
Issuance of common stock upon exercise of stock options
From December 31, 2019 to March 18, 2020
Issuance of common stock upon exercise of stock options
From December 31, 2018 to December 31, 2019
Issuance of Series D preferred stock, net of issuance costs of $158
Conversion of Series A, B, C and D preferred stock into common stock upon initial public offering
Issuance of common stock upon initial public offering at $14.00 per share for cash, net of issuance costs of $9,386
Issuance of common stock upon exercise of stock options
From March 31, 2019 to June 30, 2019
Conversion of Series A, B, C and D preferred stock into common stock upon initial public offering
Issuance of common stock upon initial public offering at $14.00 per share for cash, net of issuance costs of $9,386
1.Common stock offered 6,000,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 15,588,756 shares of our common stock outstanding as of February 28, 2019, after giving effect to (i) the automatic conversion of 1,252,440 shares of our preferred stock into an aggregate of 14,582,161 shares of voting common stock upon closing of this offering and (ii) the automatic conversion of 328,071 shares of our preferred stock into 3,819,732 shares of non-voting Class A common stock upon the closing of this offering
3.a 11.643-for-1 split of our common stock effected on April 5, 2019
From December 31, 2018 To March 31, 2019
Issuance of Series D preferred stock, net of issuance costs of $158